| Pacific Palisades Medical Group Inc. | |
|
15200 W Sunset Blvd Suite 107 Pacific Palisades CA 90272-3619 | |
| (310) 459-7736 | |
| (310) 230-0284 |
| Full Name | Pacific Palisades Medical Group Inc. |
|---|---|
| Speciality | Family Medicine |
| Location | 15200 W Sunset Blvd, Pacific Palisades, California |
| Authorized Official Name and Position | Richard Johnson (PRESIDENT) |
| Authorized Official Contact | 3104597736 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Pacific Palisades Medical Group Inc. 15200 W Sunset Blvd Suite 107 Pacific Palisades CA 90272-3619 Ph: (310) 459-7736 | Pacific Palisades Medical Group Inc. 15200 W Sunset Blvd Suite 107 Pacific Palisades CA 90272-3619 Ph: (310) 459-7736 |
| NPI Number | 1215037049 |
|---|---|
| Provider Enumeration Date | 09/22/2006 |
| Last Update Date | 05/14/2021 |
| Medicare PECOS PAC ID | 1153393517 |
|---|---|
| Medicare Enrollment ID | O20040806001220 |
News Archive
Researchers involved with a multi-armed clinical trial designed to evaluate different antiretroviral (ARV) interventions for HIV prevention on Friday announced the arm testing a vaginal gel had been stopped because it was not working, the New York Times reports.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.
A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215037049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Krystyna E Mcnicoll |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1750392247 PECOS PAC ID: 7416929872 Enrollment ID: I20040807000231 |
News Archive
Researchers involved with a multi-armed clinical trial designed to evaluate different antiretroviral (ARV) interventions for HIV prevention on Friday announced the arm testing a vaginal gel had been stopped because it was not working, the New York Times reports.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.
A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.
› Verified 6 days ago
| Provider Name | Gary A Green |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1154345254 PECOS PAC ID: 8325010788 Enrollment ID: I20040807000241 |
News Archive
Researchers involved with a multi-armed clinical trial designed to evaluate different antiretroviral (ARV) interventions for HIV prevention on Friday announced the arm testing a vaginal gel had been stopped because it was not working, the New York Times reports.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.
A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.
› Verified 6 days ago
| Provider Name | Richard A Johnson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1770596009 PECOS PAC ID: 4789656141 Enrollment ID: I20040807000247 |
News Archive
Researchers involved with a multi-armed clinical trial designed to evaluate different antiretroviral (ARV) interventions for HIV prevention on Friday announced the arm testing a vaginal gel had been stopped because it was not working, the New York Times reports.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.
A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.
› Verified 6 days ago
| Provider Name | Julie M Ma |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1306865688 PECOS PAC ID: 6507838968 Enrollment ID: I20040807000259 |
News Archive
Researchers involved with a multi-armed clinical trial designed to evaluate different antiretroviral (ARV) interventions for HIV prevention on Friday announced the arm testing a vaginal gel had been stopped because it was not working, the New York Times reports.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.
A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.
› Verified 6 days ago
| Provider Name | Ericka M Gair |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1376660704 PECOS PAC ID: 8325221401 Enrollment ID: I20110328000343 |
News Archive
Researchers involved with a multi-armed clinical trial designed to evaluate different antiretroviral (ARV) interventions for HIV prevention on Friday announced the arm testing a vaginal gel had been stopped because it was not working, the New York Times reports.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.
A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.
› Verified 6 days ago
News Archive
Researchers involved with a multi-armed clinical trial designed to evaluate different antiretroviral (ARV) interventions for HIV prevention on Friday announced the arm testing a vaginal gel had been stopped because it was not working, the New York Times reports.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.
A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.
› Verified 6 days ago
Uc Regents Ucla Dept Of Medicine Prof Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15200 W Sunset Blvd, Pacific Palisades, CA 90272 Phone: 310-230-0284 | |
Na Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 16820 Edgar St, Pacific Palisades, CA 90272 Phone: 310-459-2597 Fax: 310-268-4086 | |
Damon B. Raskin Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 881 Alma Real Dr, Suite 103, Pacific Palisades, CA 90272 Phone: 310-459-4333 Fax: 310-454-4707 | |
Lori A Musto, Do Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 881 Alma Real Dr Ste 110, Pacific Palisades, CA 90272 Phone: 310-454-1212 | |
Michael R Block M D Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 970 Monument St, Suite 210, Pacific Palisades, CA 90272 Phone: 310-459-4321 Fax: 310-459-5326 | |
Robert M Kahn Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 881 Alma Real Dr, Suite 103, Pacific Palisades, CA 90272 Phone: 310-459-4333 Fax: 310-454-4707 |